GlassScriptPhysician profile
Lisa K Higa
NPI 1669583167
$1,067.33
in general payments reported to CMS, 2019-2025
8 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.05 · 2020: $63.16 · 2021: $134 · 2022: $21.40 · 2023: $149 · 2024: $86.33 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $413.51 | 2019-2025 | |
| Janssen Biotech, INC. | $204.65 | 2019-2025 | Tremfya, Stelara |
| 3-D Matrix, INC. | $187.50 | 2025 | |
| Madrigal Pharmaceuticals | $103.84 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $86.72 | 2020-2024 | Entyvio |
| Allergan, INC. | $36.32 | 2019-2020 | |
| Qol Medical, LLC | $19.23 | 2023 | Sucraid |
| Celgene Corporation | $15.56 | 2023 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Higa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.